Act Wealth Management, LLC Aim Immuno Tech Inc. Transaction History

Act Wealth Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 08, 2021	SELL	$1.88 - $2.82 $18,800 - $28,200	-10,000 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$1.68 - $2.45 $16,800 - $24,500	10,000 New	10,000 $18,000

9.01M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $10.1M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Act Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Act Wealth Management, LLC with notifications on news.